Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (99.54 KB, 1 trang )
in reducing the recurrence rate. Finally, any identified source of the fever should
be properly treated.
Suggested Readings and Key References
Aaberg KM, Gunnes N, Bakken IJ, et al. Incidence and prevalence of childhood
epilepsy: a nationwide cohort study. Pediatrics 2017;139(5):e20163908.
Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric
status epilepticus: a randomized clinical trial. JAMA 2014;311:1652–1660.
Cui W, Kobau R, Zack MM, et al. Seizures in children and adolescents aged 6–17
years—United States, 2010–2014. MMWR Morb Mortal Wkly Rep
2015;64:1209–1214.
Dalziel SR, Borland ML, Furyk J, et al. Levetiracetam versus phenytoin for
second-line treatment of convulsive status epilepticus in children (ConSEPT):
an open-label, multicentre, randomised controlled trial. Lancet
2019;393(10186):2135–2145.
Available
from
/>Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types
by the international league against epilepsy: position paper of the ILAE
commission for classification and terminology. Epilepsia 2017;58:522–530.
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: Treatment of
convulsive status epilepticus in children and adults: report of the guideline
committee of the American epilepsy society. Epilepsy Curr 2016; 16:48–61.
İşgüder R, Güzel O, Ceylan G, et al. A comparison of intravenous levetiracetam
and valproate for the treatment of refractory status epilepticus in children. J
Child Neurol 2016;31:1120–1126.
Kapur J, Elm J, Chamberlain JM, et al. Trial of three anticonvulsant medications
for status epilepticus. N Eng J Med 2019;381(22):2103–2113.
Kimia AA, Bachur RG, Torres A, et al. Febrile seizures: emergency medicine
perspective. Curr Opin Pediatr 2015;27(3):292–297.
Lyttle MD, Rainford NEA, Gamble C, et al. Levetiracetam versus phenytoin for
second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a